Company intelligence / Profile preview

Specialized Life Sciences Company

Victoria, Canadacytivalifesciences.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Emergent BioSolutions develops, manufactures, and supplies medical countermeasures for national security and public health preparedness. It has commercial products addressing endemic threats like opioid overdose and infectious disease agents such as anthrax. The company also provides CDMO services for biopharma innovators.

Therapeutic areas: NeurologyInfectious Diseases
Modalities: VaccineAntibodySmall moleculeBiologic
Industry: Biotech

Drug pipeline

1 asset

TATX-03

Pre-clinical

Indications: COVID-19

Partnerships

Government agencies (U.S. government contracts)biopharma innovators via CDMO partnerships

Beyond the preview

Go deeper on Specialized Life Sciences Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Specialized Life Sciences Company.

Explore the full profile